HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Montelukast effects on inflammation in allergic rhinitis: a double blind placebo controlled pilot study.

Abstract
It has been demonstrated that Leukotriene modifiers reduce rhinitis symptoms, but montelukast preventive effect on inflammatory cells pattern in intranasal challenge studies has not been already assessed. This pilot study has been designed to explore the montelukast effects in preventing early/late inflammatory cells response to specific allergen challenge in persistent rhinitis. After a 4 week wash-out period, patients were randomised to receive montelukast/placebo for 4 weeks. Pre-post treatment nasal washing and scraping before and after specific nasal challenge were performed. No difference in baseline inflammatory cells count before and after treatment was shown between groups. Despite at a basal level a decrease of inflammatory cells in active group after treatment was observed, the statistical significance was not reached. The generalised mixed model showed that, after therapeutic interventions, the inflammatory cells increased 30' and 6 hour after challenge but, only in the active group the cells amounting was less for eosinophils (-34%), macrophages (-56%), lymphocytes (-45%) and neutrophils (-46%; p = 0.001). The longitudinal generalised linear model with just one time variable showed a decrease of all inflammatory cellular types although a significant relevance was reached only for macrophages (p = 0.038) and neutrophils (p = 0.001). The modulatory effect on neutrophils and macrophages could lead to montelukast still unexplored effects. Specific trials, sized according to the results of this pilot exploratory study, could add relevant evidences concerning the leukotrienes receptors antagonist treatment of specific rhinitis and asthma phenotypes.
AuthorsF Braido, A M Riccio, A Rogkakou, P Massacane, L Guerra, F Fumagalli, E Stagi, S Balestracci, A Porcu, G W Canonica
JournalEuropean annals of allergy and clinical immunology (Eur Ann Allergy Clin Immunol) Vol. 44 Issue 2 Pg. 48-53 (Apr 2012) ISSN: 1764-1489 [Print] Italy
PMID22768723 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetates
  • Cyclopropanes
  • Leukotriene Antagonists
  • Quinolines
  • Sulfides
  • montelukast
Topics
  • Acetates (therapeutic use)
  • Adult
  • Cell Count
  • Cyclopropanes
  • Double-Blind Method
  • Eosinophils (drug effects, immunology)
  • Female
  • Humans
  • Hypersensitivity (immunology, prevention & control)
  • Inflammation (immunology, prevention & control)
  • Leukotriene Antagonists (therapeutic use)
  • Lymphocytes (drug effects, immunology)
  • Macrophages (drug effects, immunology)
  • Male
  • Neutrophils (drug effects, immunology)
  • Pilot Projects
  • Quinolines (therapeutic use)
  • Rhinitis, Allergic, Perennial (immunology, prevention & control)
  • Sulfides

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: